Susanne Michel MD, MSc

Co-founder
Ascenian Consulting, Germany
Susanne is a co-founder of Ascenian Consulting and responsible for Market Access and HTA. She has more than 11 years of experience of market access consulting and delivering measurable business results in new product development and repositioning products on the market. Typical projects include clinical trial assessment, payer positioning, value strategy, and pricing strategy. After working for the Ministry of Health in Berlin as senior adviser and followed by time at as a clinical trial assessor at IQWIG, Susanne joined the Department of Health in England where she was a strategy policy leader for six years when NICE was established and conducted clinical assessments at NICE. Susanne has worked for Pricewaterhouse Coopers in Luxembourg leading the Health Research Institute Europe and was responsible for the assessment of in licensing opportunities in cell and gene therapies. Susanne holds a medical degree and a Masters in Strategy from London School of Economics and Political Science. Susanne is located in Paris and Berlin.

Events/Masterclasses Susanne Michel MD, MSc is currently speaking at

Pharma

HTA & Evidence Requirements
20 - 22 June 2022
Online Live Stream | 14:00 CEST – 17:30 CEST
This unique course provides a practical & in-depth understanding of HTA decision making across EU markets and will focus on the evidence generation underpinning a convincing value proposition to different HTAs.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Susanne Michel MD, MSc
Co-founder
Ascenian Consulting, Germany
Susanne is a co-founder of Ascenian Consulting and responsible for Market Access and HTA. She has more than 11 years of experience of market access consulting and delivering measurable business results in new product development and repositioning products on the market. Typical projects include clinical trial assessment, payer positioning, value strategy, and pricing strategy. After working for the Ministry of Health in Berlin as senior adviser and followed by time at as a clinical trial assessor at IQWIG, Susanne joined the Department of Health in England where she was a strategy policy leader for six years when NICE was established and conducted clinical assessments at NICE. Susanne has worked for Pricewaterhouse Coopers in Luxembourg leading the Health Research Institute Europe and was responsible for the assessment of in licensing opportunities in cell and gene therapies. Susanne holds a medical degree and a Masters in Strategy from London School of Economics and Political Science. Susanne is located in Paris and Berlin.
Susanne Michel MD, MSc
Description
eskisehir eskort -
SEO Ajansı
- memur maaşı hesaplama - eskort - https://denemebonusuz.com - istanbul avukat